Skip to Main Content

Advertisement

Skip Nav Destination

Abstract CT192: Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2

Cancer Res (2019) 79 (13_Supplement): CT192.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • David S. Ettinger
  • Douglas E. Wood
  • Dara L. Aisner
  • Wallace Akerley
  • Jessica R. Bauman
  • Ankit Bharat
  • Debora S. Bruno
  • Joe Y. Chang
  • Lucian R. Chirieac
  • Thomas A. D’Amico
  • Malcolm DeCamp
  • Thomas J. Dilling
  • Jonathan Dowell
  • Scott Gettinger
  • Travis E. Grotz
  • Matthew A. Gubens
  • Aparna Hegde
  • Rudy P. Lackner
  • Michael Lanuti
  • Jules Lin
  • Billy W. Loo
  • Christine M. Lovly
  • Fabien Maldonado
  • Erminia Massarelli
  • Daniel Morgensztern
  • Thomas Ng
  • Gregory A. Otterson
  • Jose M. Pacheco
  • Sandip P. Patel
  • Gregory J. Riely
  • Jonathan Riess
  • Steven E. Schild
  • Theresa A. Shapiro
  • Aditi P. Singh
  • James Stevenson
  • Alda Tam
  • Tawee Tanvetyanon
  • Jane Yanagawa
  • Stephen C. Yang
  • Edwin Yau
  • Kristina Gregory
  • Miranda Hughes
Journal of the National Comprehensive Cancer Network (2022) 20 (5): 497.
  • Alexander Drilon
  • Chelsea Jenkins
  • Sudarshan Iyer
  • Adam Schoenfeld
  • Clare Keddy
  • Monika A. Davare
Nature Reviews Clinical Oncology (2021) 18 (1): 35.
  • Paula Chu
  • Miranta Antoniou
  • Mohit K Bhutani
  • Amine Aziez
  • Monica Daigl
Journal of Comparative Effectiveness Research (2020) 9 (12): 861.
  • Justin A. Chen
  • Jonathan W. Riess
Current Treatment Options in Oncology (2020) 21 (7)
  • Nicholas P. Giustini
  • Lyudmila Bazhenova
Thoracic Surgery Clinics (2020) 30 (2): 147.
Close Modal

or Create an Account

Close Modal
Close Modal